Biosimilars Growth At Biogen Still Pending As Unfavorable Market Takes Its Toll
Company Expects Significant Contributions From Byooviz From Next Year
Biogen expects impending biosimilar launches to stimulate new growth, while unfavorable market conditions have taken their toll on the company.
